This episode explores how artificial intelligence and machine learning allow biopharmaceutical companies to quickly and cost-effectively bring new products to market.  This exciting new technology unlocks the door for discovering therapies in rare diseases and other unmet medical conditions that were once too costly and time consuming to develop.